Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Systemic mastocytosis in adults: a review on prognosis and treatment based on 342 Mayo Clinic patients and current literature.

Current opinion in hematology - 1 Mar 2010

Pardanani Animesh, Tefferi Ayalew

Abstract excerpt

PURPOSE OF REVIEW: Systemic mastocytosis is a neoplastic disease of mast cells that often harbors a KIT mutation and involves the bone marrow. The current review provides an update on prognosis and treatment of systemic mastocytosis, including investigational drug therapy. RECENT FINDINGS: We have recently examined survival data and treatment outcome in 342 adult patients with systemic mastocytosis seen at our...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to KIT gene
Share to TET2 gene
Share to Interferon-alpha

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mastocytosis, Systemic

Share to Mutation

Share to Prognosis

Share to Proto-Oncogene Proteins c-kit

Share to Treatment Outcome

Source

Identifiers

PMID: 20075725
DOI: 10.1097/MOH.0b013e3283366c59

Genes

KIT
TET2

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Systemic mastocytosis in adults: a review on prognosis and treatment based on 342 Mayo Clinic patients and current literature.PMID 20075725Read ↗

Advanced systemic mastocytosis: from molecular and genetic progress to clinical practice.Semantic proximity Read ↗

Systemic mastocytosis for the practicing clinician: overview, diagnostic features, prognostication and antiproliferative treatment in the era of targeted therapy.Semantic proximity Read ↗

Systemic mastocytosis in adults: 2015 update on diagnosis, risk stratification, and management.Semantic proximity Read ↗

Systemic mastocytosis in adults: 2013 update on diagnosis, risk stratification, and management.Semantic proximity Read ↗

Advanced systemic mastocytosis: the impact of KIT mutations in diagnosis, treatment, and progression.Semantic proximity Read ↗

Diagnosis, progression patterns and prognostication in mastocytosis.Semantic proximity Read ↗

How we diagnose and treat systemic mastocytosis in adults.Semantic proximity Read ↗

Systemic mastocytosis with associated clonal hematologic nonmast cell lineage disease: a clinicopathologic review.Semantic proximity Read ↗

Mastocytosis among elderly patients: A multicenter retrospective French study on 53 patients.Semantic proximity Read ↗

Comprehensive Mastocytosis Data Analysis From A Single CenterSemantic proximity Read ↗

Advances and controversies in the diagnosis, pathogenesis, and treatment of systemic mastocytosisSemantic proximity Read ↗

KIT-Targeting Drugs in the Management of Nonadvanced and Advanced Systemic Mastocytosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.